Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Veracyte

News headline image
Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
OPTIMA Trial Results to Be Presented at ASCO Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces that Data for Its Genomic and Immuno-Oncology Offerings Will Be Highlighted at the 2022 ASCO Annual Meeting
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte Completes Acquisition of HalioDx
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte to Present at Upcoming Investor Conferences
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Data for Pulmonology Portfolio to be Presented at American Thoracic Society 2021 International Conference
From Veracyte
Via Business Wire
Tickers VCYT
News headline image
Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test
From Veracyte
Via Business Wire
Tickers VCYT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.